Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia
the goal of this observational study is to evaluate the clinical characteristic and outcomes of patients with community-acquired pneumonia admitted to Sohag University Hospital.
the researcher will take medical history and clinical examination and investigations of participants .
the participants will visit the clinic after one month to be reevaluated again .
Study Overview
Status
Conditions
Detailed Description
Community acquired pneumonia is acute infection of the pulmonary parenchyma that occurs in the community in a patient who has not been hospitalized within 14 days prior to onset of symptoms or hospitalized less than 2 days prior to the onset of symptoms the aim of the study typically focuses on examining the various factors that influence the presentation, management, and outcomes of individuals diagnosed with pneumonia that is acquired outside of a hospital or healthcare setting.
Type of the study: observational study
Outcomes of interest include:
I. Mortality (in hospital and 30 days). II. The need for further mechanical ventilation or ICU admission. III. Duration of hospital stay.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rania Abdo Saeed Rania Abdo saeed, MBBCh
- Phone Number: +2001093776651
- Email: rania_abdo_post@med.sohag.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The study will include patients ≥18 years old with community acquired pneumonia
Exclusion Criteria:
- Patients already was diagnosed as active malignancy before admission
- Patient on chemotherapy
- HIV patients
- Indication of mechanical ventilation on admission
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improved
Time Frame: within one month
|
when the patient is improved and discharged
|
within one month
|
|
patients developed complications
Time Frame: within one month
|
when patients developed complications like acute kidney injury , septic shock or Disseminated intravascular coagulopathy
|
within one month
|
|
Death of patient
Time Frame: within one month
|
within one month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
intensive care unit admission
Time Frame: within one month
|
within one month
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Han X, Liu X, Chen L, Wang Y, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Cao B; CAP-China network. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis. 2020 Sep 12;20(1):668. doi: 10.1186/s12879-020-05362-3.
- Iqbal N, Irfan M, Siddique F, Arshad V, Zubairi ABS. Factors predicting in-hospital mortality among patients admitted with community acquired pneumonia at a tertiary care hospital Karachi, Pakistan. Clin Respir J. 2020 Apr;14(4):328-334. doi: 10.1111/crj.13137. Epub 2020 Jan 2.
- Elsener C, Beeler PE, Battegay E, Bello B, Thienemann F. Risk Factors of In-Hospital Mortality in Patients Treated for Pneumonia at a Tertiary Care Centre in Switzerland. Respiration. 2020;99(8):637-645. doi: 10.1159/000508666. Epub 2020 Jul 7.
- Li HY, Guo Q, Song WD, Zhou YP, Li M, Chen XK, Liu H, Peng HL, Yu HQ, Chen X, Liu N, Lu ZD, Liang LH, Zhao QZ, Jiang M. Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted Mortality. Medicine (Baltimore). 2015 Sep;94(36):e1474. doi: 10.1097/MD.0000000000001474. Erratum In: Medicine (Baltimore). 2017 Jan 20;96(3):e6015. doi: 10.1097/MD.0000000000006015. Medicine (Baltimore). 2019 Aug;98(33):e16914. doi: 10.1097/MD.0000000000016914.
- Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020 Oct 5;12:11. doi: 10.1186/s41479-020-00074-3. eCollection 2020.
- 1. Somberg J. Harrisons, Princiole of Internal Medicine. 20th ed. LWW; 2005
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-24-09-01MS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.